Testing includes microsatellite instability (MSI) analysis to identify patients who may be candidates for immunotherapy or MSI-indicated clinical trials

  • Designed for use in solid tumors
  • May help identify Lynch Syndrome in colon and endometrial cancers

Markers interrogated by the MSI analysis
Multiplexed markers
  BAT‑25, BAT‑26, MONO‑27, NR‑21, NR‑24